Back

Limitations of current ICD indications in ischemic cardiomyopathy

9 April 2024 (10:45 - 11:00)
Organised by: Logo
Congress Presentation Part of: Update on sudden cardiac death – Focus on PROFID EHRA & RESET-CRT Ventricular Arrhythmias and Sudden Cardiac Death (SCD) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Jens Cosedis Nielsen

Aarhus University Hospital, Aarhus (Denmark)

4 More presentations in this session

Presentation thumbnail
Generating evidence for future guidelines for primary prevention ICD implantation in ischemic cardiomyopathy : the PROFID EHRA trial
Professor M. Taborsky (Usti Nad Labem, CZ)
Slides Video
Presentation thumbnail
Primary prevention ICD implantation in ischemic cardiomyopathy: summary and take home messages
Professor R. Lenarczyk (Zabrze, PL)
Slides Video
Presentation thumbnail
Cardiac resynchronisation therapy: the role of the defibrillator
Professor V. Kutyifa (Rochester, US)
Slides Video
Presentation thumbnail
Take home messages
Doctor N. Dagres (Berlin, DE)

Access the full session

Session thumbnail
Update on sudden cardiac death – Focus on PROFID EHRA & RESET-CRT
Video

The Event

Event poster

EHRA 2024

9 April 2024 10:45 CET
You may be interested in
thumbnail
Congress Session
Update on sudden cardiac death – Focus on PROFID EHRA & RESET-CRT
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: pro
thumbnail
Congress Presentation
Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources